share_log

These Analysts Revise Their Forecasts On Zscaler After Q1 Results

Benzinga ·  Dec 3 21:22

Zscaler Inc (NASDAQ:ZS) reported better-than-expected fiscal first-quarter financial results after the market close on Monday.

Zscaler reported first-quarter revenue of $628 million, beating the consensus estimate of $606.19 million. The cybersecurity company reported adjusted earnings of 77 cents per share, beating analyst estimates of 63 cents per share, according to Benzinga Pro.

"Growing customer engagements and strong sales execution drove a solid first quarter with all metrics exceeding our guidance. The combination of Zero Trust and AI is creating exciting new opportunities, which we are well positioned to capture with our large and expanding platform," said Jay Chaudhry, chairman and CEO of Zscaler.

Zscaler expects fiscal second-quarter revenue to be in the range of $633 million to $635 million versus estimates of $633.84 million. The company anticipates second-quarter adjusted earnings of 68 cents to 69 cents per share versus estimates of 69 cents per share. Zscaler expects full-year 2025 revenue of approximately $2.623 billion to $2.643 billion. The company anticipates full-year adjusted earnings of $2.94 to $2.99 per share.

Zscaler shares gained 0.9% to close at $208.51 on Monday.

These analysts made changes to their price targets on Zscaler following earnings announcement.

  • Canaccord Genuity analyst Kingsley Crane maintained Zscaler with a Buy rating and raised the price target from $220 to $230.
  • Deutsche Bank analyst Patrick Colville maintained Zscaler with a Buy and raised the price target from $200 to $225.
  • Morgan Stanley analyst Hamza Fodderwala maintained the stock with an Equal-Weight rating and lowered the price target from $215 to $205.
  • Piper Sandler analyst Rob Owens maintained Zscaler with an Overweight and increased the price target from $215 to $235.

Considering buying ZS stock? Here's what analysts think:

big

Read This Next:

  • Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 4% Dividend Yields
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment